Alfred Mahr focuses on Vasculitis, Internal medicine, Surgery, Microscopic polyangiitis and Anti-neutrophil cytoplasmic antibody. His biological study spans a wide range of topics, including Rheumatism, Proteinuria and Immunology. His Immunology research is multidisciplinary, incorporating perspectives in Meta-analysis and Disease.
Many of his studies involve connections with topics such as Gastroenterology and Internal medicine. His Surgery research focuses on Granulomatosis with polyangiitis and how it connects with Eosinophilic. His Microscopic polyangiitis research incorporates themes from Survival analysis, Epidemiology and Polyarteritis nodosa.
Alfred Mahr mainly investigates Vasculitis, Internal medicine, Immunology, Surgery and Microscopic polyangiitis. His research in Vasculitis intersects with topics in Vascular disease and Intensive care medicine. His Internal medicine study frequently draws connections to adjacent fields such as Gastroenterology.
As part of one scientific family, Alfred Mahr deals mainly with the area of Immunology, narrowing it down to issues related to the Disease, and often Epidemiology. As part of his studies on Microscopic polyangiitis, Alfred Mahr often connects relevant areas like Polyarteritis nodosa. His biological study deals with issues like Eosinophilic, which deal with fields such as Churg strauss.
His primary scientific interests are in Internal medicine, Giant cell arteritis, Dermatology, Clinical trial and Systematic review. His research links Placebo with Internal medicine. Alfred Mahr works mostly in the field of Giant cell arteritis, limiting it down to concerns involving Incidence and, occasionally, Epidemiology, National health insurance, Pediatrics and Menopause.
His studies deal with areas such as Physical therapy and Randomized controlled trial as well as Clinical trial. Alfred Mahr has researched Immunology in several fields, including Genetics, Vasculitis, Microscopic polyangiitis and Genome-wide association study. His work on Anti-neutrophil cytoplasmic antibody as part of general Vasculitis research is frequently linked to Oral cavity, bridging the gap between disciplines.
His main research concerns Internal medicine, Giant cell arteritis, Clinical trial, Systematic review and Adverse effect. In the subject of general Internal medicine, his work in Rheumatology, Meta-analysis and Birmingham Vasculitis Activity Score is often linked to Standardized test and Quality of life, thereby combining diverse domains of study. He combines subjects such as Large vessel vasculitis, Guideline, Polymyalgia rheumatica, Vasculitis and Physical therapy with his study of Rheumatology.
His work deals with themes such as Skin pathology and Consensus conference, which intersect with Vasculitis. His Giant cell arteritis research is multidisciplinary, relying on both Diabetes mellitus, Mortality rate and Cause of death, Death certificate. His Adverse effect research incorporates themes from Mucocutaneous zone, Placebo, Rheumatism, Behcet's disease and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette;R. J. Falk;P. A. Bacon;N. Basu.
Arthritis & Rheumatism (2013)
Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies
Richard Watts;Suzanne Lane;Thomas Hanslik;Thomas Hauser.
Annals of the Rheumatic Diseases (2006)
Revised international Chapel Hill consensus conference nomenclature of vasculitides
J. C. Jennette;R. J. Falk;P. Bacon;N Basu.
(2013)
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.
M. Yates;M. Yates;R. A. Watts;I. M. Bajema;M. C. Cid.
Annals of the Rheumatic Diseases (2016)
Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
Loïc Guillevin;Christian Pagnoux;Alexandre Karras;Chahera Khouatra.
The New England Journal of Medicine (2014)
Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss Syndrome
Régis Sablé-Fourtassou;Pascal Cohen;Alfred Mahr;Christian Pagnoux.
Annals of Internal Medicine (2005)
Long-term patient survival in ANCA-associated vasculitis
Oliver Flossmann;Annelies Berden;Kirsten de Groot;Chris Hagen.
Annals of the Rheumatic Diseases (2011)
Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort
Cloé Comarmond;Christian Pagnoux;Mehdi Khellaf;Jean-François Cordier.
Arthritis & Rheumatism (2013)
The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.
Loïc Guillevin;Christian Pagnoux;Raphaele Seror;Alfred Mahr.
Medicine (2011)
Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Christian Pagnoux;Alfred Mahr;Mohamed A. Hamidou;Jean-Jacques Boffa.
The New England Journal of Medicine (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Université Paris Cité
University of Cambridge
Université Paris Cité
Mayo Clinic
Université Paris Cité
Cleveland Clinic
Université Paris Cité
Harvard University
University of Modena and Reggio Emilia
Mayo Clinic
University of Nottingham
National Technical University of Athens
University of Ottawa
ETH Zurich
Heidelberg University
Oak Ridge National Laboratory
University of the Sunshine Coast
Aarhus University
Saitama Medical University
Robert Koch Institute
University of Lorraine
Heidelberg University
University of Nebraska Medical Center
University of York
University of Oxford
University of Arizona